全文获取类型
收费全文 | 2813篇 |
免费 | 157篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 67篇 |
妇产科学 | 77篇 |
基础医学 | 427篇 |
口腔科学 | 95篇 |
临床医学 | 207篇 |
内科学 | 646篇 |
皮肤病学 | 45篇 |
神经病学 | 193篇 |
特种医学 | 90篇 |
外科学 | 527篇 |
综合类 | 15篇 |
预防医学 | 86篇 |
眼科学 | 39篇 |
药学 | 155篇 |
中国医学 | 1篇 |
肿瘤学 | 299篇 |
出版年
2023年 | 15篇 |
2022年 | 29篇 |
2021年 | 63篇 |
2020年 | 49篇 |
2019年 | 73篇 |
2018年 | 75篇 |
2017年 | 47篇 |
2016年 | 59篇 |
2015年 | 61篇 |
2014年 | 91篇 |
2013年 | 148篇 |
2012年 | 184篇 |
2011年 | 229篇 |
2010年 | 109篇 |
2009年 | 121篇 |
2008年 | 171篇 |
2007年 | 178篇 |
2006年 | 161篇 |
2005年 | 132篇 |
2004年 | 129篇 |
2003年 | 111篇 |
2002年 | 122篇 |
2001年 | 91篇 |
2000年 | 62篇 |
1999年 | 71篇 |
1998年 | 18篇 |
1997年 | 19篇 |
1996年 | 14篇 |
1995年 | 15篇 |
1994年 | 16篇 |
1993年 | 11篇 |
1992年 | 34篇 |
1991年 | 20篇 |
1990年 | 39篇 |
1989年 | 39篇 |
1988年 | 20篇 |
1987年 | 24篇 |
1986年 | 16篇 |
1985年 | 18篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1974年 | 7篇 |
1973年 | 6篇 |
1970年 | 7篇 |
1967年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有2975条查询结果,搜索用时 17 毫秒
941.
JR Carey HG Müller JL Wang NT Papadopoulos A Diamantidis NA Koulousis 《Experimental gerontology》2012,47(10):787-791
The purpose of this paper is to complement the literature concerned with the captive cohort method for estimating age structure including (1) graphic techniques to visualize and thus better understand the underlying life table identity in which the age structure of a stationary population equals the time-to-death distribution of the individuals within it; (2) re-derive the basic model for estimating age structure in non-stationary population in demographic rather than statistical notation; and (3) describe a simplified method for estimating changes in the mean age of a wild population. 相似文献
942.
943.
944.
945.
Audrey Le Floc’h Jeanne Allinne Kirsten Nagashima George Scott Dylan Birchard Seblewongel Asrat Yu Bai Wei Keat Lim Joel Martin Tammy Huang Terra B. Potocky Jee H. Kim Ashique Rafique Nicholas J. Papadopoulos Neil Stahl George D. Yancopoulos Andrew J. Murphy Matthew A. Sleeman Jamie M. Orengo 《Allergy》2020,75(5):1188-1204
946.
Annabelle Bédard Josep M. Antó Joao A. Fonseca Sylvie Arnavielhe Claus Bachert Anna Bedbrook Carsten Bindslev-Jensen Sinthia Bosnic-Anticevich Victoria Cardona Alvaro A. Cruz Wytske J. Fokkens Judith Garcia-Aymerich Peter W. Hellings Juan C. Ivancevich Ludger Klimek Piotr Kuna Violeta Kvedariene Désirée Larenas-Linnemann Erik Melén Ricardo Monti Ralf Mösges Joaquim Mullol Nikos G. Papadopoulos Nhân Pham-Thi Boleslaw Samolinski Peter V. Tomazic Sanna Toppila-Salmi Maria Teresa Ventura Arzu Yorgancioglu Jean Bousquet Oliver Pfaar Xavier Basagaña the MASK study group 《Allergy》2020,75(7):1672-1688
947.
Nikolaos G. Papadopoulos Peter Barnes Giorgio Walter Canonica Mina Gaga Liam Heaney Andrew Menzies-Gow Vicky Kritikos Mark Fitzgerald 《Allergy》2020,75(7):1555-1563
New therapeutic options for severe asthma have recently emerged, mostly in the form of monoclonal antibodies (“biologicals”) targeting relevant inflammatory pathways. Currently available agents target different aspects of “Type 2” immunity, and their indications often include overlapping patient groups. We present a round-table discussion that took place during the Annual Meeting of the Respiratory Effectiveness Group (REG), on the reasoning behind the use of different add-on medications for severe asthma, and crucially, on selection strategies. The proposed rational is based on current evidence, including real-life studies, as well as on the appreciation of the relevant complexities. Direct head-to-head comparisons of biologicals are lacking; therefore, algorithms for initial choice and potential switch between agents should be based on understanding the key characteristics of different options and the development of a clear plan with predefined targets and shared decision-making, in a structured way. 相似文献
948.
Gunjan L. Shah Susan DeWolf Yeon Joo Lee Roni Tamari Parastoo B. Dahi Jessica A. Lavery Josel Ruiz Sean M. Devlin Christina Cho Jonathan U. Peled Ioannis Politikos Michael Scordo N. Esther Babady Tania Jain Santosha Vardhana Anthony Daniyan Craig S. Sauter Juliet N. Barker Sergio A. Giralt Cheryl Goss Peter Maslak Tobias M. Hohl Mini Kamboj Lakshmi Ramanathan Marcel R.M. van den Brink Esperanza Papadopoulos Genovefa Papanicolaou Miguel-Angel Perales 《The Journal of clinical investigation》2020,130(12):6656
949.
Ken-Dror G Humphries SE Kumari M Kivimaki M Drenos F 《European journal of epidemiology》2012,27(4):267-279
Mendelian randomization studies on fibrinogen commonly use a single genetic variant as an instrument, but this may explain only a small proportion of the total phenotypic variance. We examined the contribution of multiple common single nucleotide polymorphisms (SNPs) and haplotypes in the entire fibrinogen gene cluster to plasma fibrinogen levels in two prospective cohorts, for use as instruments in future Mendelian randomization studies. Genotypes for 20 SNPs were determined in 2,778 middle-age (49-64 years) men from the Second-Northwick-Park-Heart Study (NPHS-II). These were replicated in 3,705 men from the Whitehall-II study (WH-II). Plasma fibrinogen levels were determined six times in NPHS-II and three times in WH-II. The minor alleles of four SNPs from the FGB gene, two from the FGA gene, and one from the FGG gene were associated with higher plasma fibrinogen levels. SNP rs1800790 (-455G>A) commonly used in Mendelian randomization studies was associated with R2=1.22% of the covariate adjusted residual variance in fibrinogen level. A variable selection procedure identified one additional SNP: rs2070011 (FGA) altogether explaining R2=1.45% of the residual variance in fibrinogen level. Using these SNPs no evidence for causality between the fibrinogen levels and coronary heart diseases was found in instrumental variables analysis. In the replication cohort, WH-II, the effects of the two SNPs on fibrinogen levels were consistent with the NPHS-II results. There is statistical evidence for several functional sites in the fibrinogen gene cluster that determine an individual's plasma fibrinogen levels. Thus, a combination of several SNPs will provide a stronger instrument for fibrinogen Mendelian randomization studies. 相似文献